{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:20:29Z","timestamp":1744172429855,"version":"3.40.3"},"reference-count":167,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T00:00:00Z","timestamp":1736035200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100011744","name":"National University Health System","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011744","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Medicinal Research Reviews"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>The Semliki Forest virus (SFV) complex comprises of arboviruses that are transmitted by arthropod vectors and cause acute febrile illness in humans. In the last seven decades, re\u2010emergence of these viruses has resulted in numerous outbreaks globally, affecting regions including Africa, Americas, Asia, Europe and the Caribbean. These viruses are transmitted to humans by the bite of infected mosquitoes. Symptoms of infection include high fever, severe joint pain, skin rash, muscle pain and headache. Fatal cases were reported, and mortality rate increased during the epidemic of these viruses. There is therefore a need to control the spread of these emerging arboviruses. Given that vaccination is one of the most effective ways to protect populations against viral outbreaks, efforts have been made to develop and test potential vaccine candidates. However, there are still no licensed vaccines available against the medically important viruses in the SFV complex. This review first summarizes the current knowledge of the SFV complex disease pathogenesis. Next, seven strategies that have been applied in vaccine development against these viruses are reviewed, indicating the immune response and efficacies of these vaccine candidates in in vivo models of infection. Finally, the more promising candidates that have entered clinical trials are discussed and insights into the future development of vaccines for viruses of the SFV complex are given.<\/jats:p>","DOI":"10.1002\/med.22097","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T04:54:00Z","timestamp":1736139240000},"page":"947-967","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Current Progress in the Quest for Vaccines Against the Semliki Forest Virus Complex"],"prefix":"10.1002","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1294-5736","authenticated-orcid":false,"given":"Dorothy Hui Juan","family":"Cheong","sequence":"first","affiliation":[{"name":"Department of Microbiology and Immunology, Infectious Disease Translational Research Programme, Yong Loo Lin School of Medicine National University of Singapore Singapore City Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bowen","family":"Yi","sequence":"additional","affiliation":[{"name":"Biosafety Level 3 Core Facility, Yong Loo Lin School of Medicine National University of Singapore Singapore City Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi Hao","family":"Wong","sequence":"additional","affiliation":[{"name":"Biosafety Level 3 Core Facility, Yong Loo Lin School of Medicine National University of Singapore Singapore City Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1673-6819","authenticated-orcid":false,"given":"Justin Jang Hann","family":"Chu","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Infectious Disease Translational Research Programme, Yong Loo Lin School of Medicine National University of Singapore Singapore City Singapore"},{"name":"Biosafety Level 3 Core Facility, Yong Loo Lin School of Medicine National University of Singapore Singapore City Singapore"},{"name":"Collaborative and Translation Unit for Hand, Foot and Mouth Disease (HFMD), Institute of Molecular and Cell Biology, Agency for Science, Technology and Research Singapore CIty Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,1,5]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1159\/000149190"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1128\/am.26.4.485-488.1973"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.52.2.575-582.1984"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-70-3-743"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofx163.1348"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13690-018-0284-2"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-8-99"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001197"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens9090738"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2013.05.002"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.2174\/1389557520666200316160425"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.3390\/v7072792"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(55)90080-8"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(55)90081-X"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12694"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw391"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/3-540-26397-7_10"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1086\/605496"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/trstmh\/trt083"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0009055"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.3389\/fitd.2021.737436"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid2110.141660"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid2211.161015"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2006.75.461"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.2217\/fvl.15.76"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16516-x"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid1911.130777"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.ento.47.091201.145100"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-77-3-407"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/122.1-2.45"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/127.2.129"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/20477724.2017.1355431"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(65)90012-X"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(81)90325-4"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-81-2-471"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1962.11.255"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0034-5288(18)32658-4"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0749-0739(17)30099-8"},{"issue":"4","key":"e_1_2_9_40_1","first-page":"730","article-title":"Isolation of Getah Virus From Mosquitos Collected on Hainan Island, China, and Results of a Serosurvey","volume":"23","author":"Li X. D.","year":"1992","journal-title":"Southeast Asian Journal of Tropical Medicine and Public Health"},{"issue":"2","key":"e_1_2_9_41_1","first-page":"333","article-title":"Reappearance of Getah Virus Infection Among Horses in Japan","volume":"47","author":"Sentsui H.","year":"1985","journal-title":"Japanese Journal of Veterinary Science"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12917-016-0741-5"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1005079229232"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1089\/vbz.2018.2273"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1980.29.984"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1292\/jvms1939.49.989"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(61)90025-6"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1080\/135502802901068000"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0005-2736(02)00721-6"},{"key":"e_1_2_9_50_1","first-page":"1353","article-title":"Genome Structure of Sagiyama Virus and Its Relatedness to Other Alphaviruses","volume":"81","author":"Shirako Y.","year":"2000","journal-title":"Journal of General Virology"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0036-46652003000200012"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.62.4.505"},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.1177\/003591573102401109"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.96.4.596"},{"volume-title":"Medical Microbiology","year":"1996","author":"Goldenthal K. L.","key":"e_1_2_9_55_1"},{"key":"e_1_2_9_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.02.062"},{"key":"e_1_2_9_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.07.072"},{"key":"e_1_2_9_58_1","doi-asserted-by":"publisher","DOI":"10.1093\/milmed\/141.3.163"},{"key":"e_1_2_9_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.03.089"},{"key":"e_1_2_9_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.09.125"},{"key":"e_1_2_9_61_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00546-14"},{"key":"e_1_2_9_62_1","doi-asserted-by":"publisher","DOI":"10.1128\/am.19.2.321-325.1970"},{"key":"e_1_2_9_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(94)90182-1"},{"key":"e_1_2_9_64_1","doi-asserted-by":"publisher","DOI":"10.1128\/iai.56.9.2450-2457.1988"},{"key":"e_1_2_9_65_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10081865"},{"key":"e_1_2_9_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2008.04.020"},{"key":"e_1_2_9_67_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002142"},{"key":"e_1_2_9_68_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu014"},{"key":"e_1_2_9_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.04.099"},{"key":"e_1_2_9_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2012.11.013"},{"key":"e_1_2_9_71_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002969"},{"key":"e_1_2_9_72_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-62084-x"},{"issue":"10","key":"e_1_2_9_73_1","first-page":"1268","article-title":"Stimulation of Dendritic Cell Functional Maturation by Capsid Protein From Chikungunya Virus","volume":"23","author":"Nghia V. X.","year":"2020","journal-title":"Iranian Journal of Basic Medical Sciences"},{"key":"e_1_2_9_74_1","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01970-16"},{"key":"e_1_2_9_75_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00504-19"},{"key":"e_1_2_9_76_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.02881"},{"key":"e_1_2_9_77_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.83527"},{"key":"e_1_2_9_78_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890320205"},{"key":"e_1_2_9_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2020.04.003"},{"key":"e_1_2_9_80_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197708042970503"},{"key":"e_1_2_9_81_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/125.6.656"},{"key":"e_1_2_9_82_1","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-8-353"},{"key":"e_1_2_9_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2020.112869"},{"key":"e_1_2_9_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00566-2"},{"key":"e_1_2_9_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2018.03.007"},{"key":"e_1_2_9_86_1","doi-asserted-by":"publisher","DOI":"10.2174\/1871526519666190521100521"},{"key":"e_1_2_9_87_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007466"},{"key":"e_1_2_9_88_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-018-1672-7"},{"key":"e_1_2_9_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2019.06.006"},{"key":"e_1_2_9_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2021.e06396"},{"key":"e_1_2_9_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-90248-9.00017-6"},{"key":"e_1_2_9_92_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-021-00806-7"},{"key":"e_1_2_9_93_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.22.8964"},{"key":"e_1_2_9_94_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-1417-3_9"},{"key":"e_1_2_9_95_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002124"},{"key":"e_1_2_9_96_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004782"},{"key":"e_1_2_9_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(00)00259-0"},{"key":"e_1_2_9_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.07.098"},{"key":"e_1_2_9_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymeth.2006.07.018"},{"key":"e_1_2_9_100_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.64.3.1201-1206.1990"},{"key":"e_1_2_9_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.07.054"},{"key":"e_1_2_9_102_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01860-12"},{"key":"e_1_2_9_103_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4253"},{"key":"e_1_2_9_104_1","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2021.1886598"},{"key":"e_1_2_9_105_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01963"},{"key":"e_1_2_9_106_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjp.2008.349"},{"key":"e_1_2_9_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2004.07.013"},{"key":"e_1_2_9_108_1","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens8040231"},{"key":"e_1_2_9_109_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.591885"},{"key":"e_1_2_9_110_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0009308"},{"key":"e_1_2_9_111_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.03418-13"},{"key":"e_1_2_9_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32488-7"},{"key":"e_1_2_9_113_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.05.086"},{"key":"e_1_2_9_114_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz202"},{"issue":"3","key":"e_1_2_9_115_1","first-page":"249","article-title":"Evaluation of the Efficacy Provided by a Recombinant Canarypox\u2010Vectored Equine West Nile Virus Vaccine Against an Experimental West Nile Virus Intrathecal Challenge in Horses","volume":"7","author":"Siger L.","year":"2006","journal-title":"Veterinary Therapeutics: Research in Applied Veterinary Medicine"},{"key":"e_1_2_9_116_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03662-6"},{"volume-title":"\u201cZydus Cadila: India Approves World's First DNA Covid Vaccine,\u201d","year":"2021","author":"BBC","key":"e_1_2_9_117_1"},{"key":"e_1_2_9_118_1","unstructured":"World Health Organization \u201cThe Pfizer BioNTech (BNT162b2) COVID\u201019 Vaccine: What You Need to Know \u201d2022 https:\/\/www.who.int\/news-room\/feature-stories\/detail\/who-can-take-the-pfizer-biontech-covid-19--vaccine-what-you-need-to-know."},{"key":"e_1_2_9_119_1","unstructured":"World Health Organization \u201cThe Moderna COVID\u201019 (mRNA\u20101273) Vaccine: What You Need To Know \u201d2022 https:\/\/www.who.int\/news-room\/feature-stories\/detail\/the-moderna-covid-19-mrna-1273-vaccine-what-you-need-to-know."},{"key":"e_1_2_9_120_1","unstructured":"\u201cRecombitek\u00ae Equine West Nile Virus \u201dMerial Ltd 2011."},{"key":"e_1_2_9_121_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.8.3.406"},{"key":"e_1_2_9_122_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000928"},{"key":"e_1_2_9_123_1","doi-asserted-by":"publisher","DOI":"10.1089\/vim.2012.0061"},{"key":"e_1_2_9_124_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007042"},{"key":"e_1_2_9_125_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw111"},{"key":"e_1_2_9_126_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.633776"},{"key":"e_1_2_9_127_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aaw6647"},{"key":"e_1_2_9_128_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19113605"},{"key":"e_1_2_9_129_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41578-021-00358-0"},{"key":"e_1_2_9_130_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.07.024"},{"key":"e_1_2_9_131_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrg2432"},{"key":"e_1_2_9_132_1","unstructured":"International Vaccine Institute \u201cSeamless Controlled Trial To Evaluate Safety And Immunogenicity of Chikungunya Vaccine in Latin America and Asia (IVICHIK001) \u201d2021 https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04566484."},{"key":"e_1_2_9_133_1","unstructured":"Valneva \u201cValneva Announces Initiation of Adolescent Phase 3 Trial for its Single\u2010Shot Chikungunya Vaccine Candidate \u201d2022 https:\/\/valneva.com\/press-release\/valneva-announces-initiation-of-adolescent-phase-3-trial-for-its-single-shot-chikungunya-vaccine-candidate\/."},{"key":"e_1_2_9_134_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(22)00226-2"},{"key":"e_1_2_9_135_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)70043-5"},{"key":"e_1_2_9_136_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.151095"},{"key":"e_1_2_9_137_1","unstructured":"Themis Bioscience GmbH \u201cPhase II Study to Evaluate Safety and Immunogenicity of a Chikungunya Vaccine \u201d2016 https:\/\/ClinicalTrials.gov\/show\/NCT02861586."},{"key":"e_1_2_9_138_1","unstructured":"Themis Bioscience GmbH \u201cChikungunya Vaccine Study in Previously Exposed Adults (V184\u2010006) \u201d2019 https:\/\/ClinicalTrials.gov\/show\/NCT03807843."},{"key":"e_1_2_9_139_1","unstructured":"Fierce Biotech \u201cMerck Admits Defeat in Race With Valneva to Get First Chikungunya Vaccine to Market 2023 https:\/\/www.fiercebiotech.com\/deals\/merck-admits-defeat-race-valneva-get-first-chikungunya-vaccine-market."},{"key":"e_1_2_9_140_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2018.11.058"},{"key":"e_1_2_9_141_1","unstructured":"Moderna TX Inc \u201cSafety Tolerability and Immunogenicity of VAL\u2010181388 in Healthy Subjects \u201d2017 https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03325075."},{"key":"e_1_2_9_142_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01573-6"},{"key":"e_1_2_9_143_1","unstructured":"ModernaTX Inc \u201cSafety Tolerability Pharmacokinetics and Pharmacodynamics of mRNA\u20101944 in Healthy Adults \u201d2019 https:\/\/ClinicalTrials.gov\/show\/NCT03829384."},{"key":"e_1_2_9_144_1","unstructured":"Ology Bioservices \u201cRoss River Virus (RRV) Vaccine Study \u201d2011 https:\/\/ClinicalTrials.gov\/show\/NCT01242670."},{"key":"e_1_2_9_145_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00328978"},{"key":"e_1_2_9_146_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2022.105828"},{"key":"e_1_2_9_147_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-017-2555-2"},{"key":"e_1_2_9_148_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158485"},{"key":"e_1_2_9_149_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.12.005"},{"key":"e_1_2_9_150_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.10.078"},{"key":"e_1_2_9_151_1","doi-asserted-by":"publisher","DOI":"10.3390\/v11090779"},{"key":"e_1_2_9_152_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1406035"},{"key":"e_1_2_9_153_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)30385-1"},{"key":"e_1_2_9_154_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci84417"},{"key":"e_1_2_9_155_1","doi-asserted-by":"publisher","DOI":"10.1128\/genomea.01341-15"},{"key":"e_1_2_9_156_1","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1963.12.777"},{"key":"e_1_2_9_157_1","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.14.4.909-932.2001"},{"key":"e_1_2_9_158_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.107.3.643"},{"key":"e_1_2_9_159_1","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2000.62.681"},{"key":"e_1_2_9_160_1","unstructured":"Bharat Biotech International Limited Clinical Trial to Evaluate the Immunogenicity of Chikungunya Vaccine(2017) https:\/\/ClinicalTrials.gov\/show\/NCT04603131."},{"key":"e_1_2_9_161_1","unstructured":"Emergent BioSolutions A Phase 3 Trial of the VLP\u2010Based Chikungunya Vaccine PXVX0317(2021) https:\/\/ClinicalTrials.gov\/show\/NCT05072080."},{"key":"e_1_2_9_162_1","unstructured":"Themis Bioscience GmbH Phase II Study to Evaluate Safety and Immunogenicity of a Chikungunya Vaccine(2016) https:\/\/ClinicalTrials.gov\/show\/NCT02861586."},{"key":"e_1_2_9_163_1","unstructured":"Valneva Austria GmbH Study to Demonstrate Consistency of Three Lots of a Live\u2010attenuated Chikungunya Virus Vaccine Candidate in Healthy Adults(2021) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04786444."},{"key":"e_1_2_9_164_1","unstructured":"National Institute of Allergy and Infectious Diseases Chikungunya Virus Vaccine Trial in Healthy Adults(2011) https:\/\/ClinicalTrials.gov\/show\/NCT01489358."},{"key":"e_1_2_9_165_1","unstructured":"National Institute of Allergy and Infectious Diseases Trial for Safety and Immunogenicity of a Chikungunya Vaccine VRC\u2010CHKVLP059\u201000\u2010VP in Healthy Adults(2015) https:\/\/clinicaltrials.gov\/show\/NCT02562482."},{"key":"e_1_2_9_166_1","unstructured":"Themis Bioscience GmbH Study of a Live Attenuated Chikungunya Vaccine in a Previously Epidemic Area(2017) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03101111."},{"key":"e_1_2_9_167_1","unstructured":"University of Oxford Safety and Immunogenicity of a Candidate CHIKV Vaccine (CHIK001)(2018) https:\/\/ClinicalTrials.gov\/show\/NCT03590392."},{"key":"e_1_2_9_168_1","unstructured":"Themis Bioscience GmbH Safety Tolerability and Long\u2010term Immunogenicity of Different Formulations of a Chikungunya Vaccine (V184\u2010005)(2018) https:\/\/ClinicalTrials.gov\/show\/NCT03635086."}],"container-title":["Medicinal Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/med.22097","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T11:36:32Z","timestamp":1744112192000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/med.22097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,5]]},"references-count":167,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["10.1002\/med.22097"],"URL":"https:\/\/doi.org\/10.1002\/med.22097","archive":["Portico"],"relation":{},"ISSN":["0198-6325","1098-1128"],"issn-type":[{"type":"print","value":"0198-6325"},{"type":"electronic","value":"1098-1128"}],"subject":[],"published":{"date-parts":[[2025,1,5]]},"assertion":[{"value":"2023-05-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}